🇺🇸 FDA
Patent

US 10407680

Compounds and methods for reducing Tau expression

granted A61KA61K31/7125A61K47/02

Quick answer

US patent 10407680 (Compounds and methods for reducing Tau expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K31/7125, A61K47/02, A61K47/46, A61K9/0019